<seo title="Viatris" metakeywords="viatris global healthcare,health products viatris,viatris business,products viatris" metadescription="Viatris is a global leader in the development, manufacture, and distribution of generic and specialty pharmaceuticals, biologics, and consumer health products." />
===Introduction to Viatris===

Viatris is a global healthcare company that was formed in 2020 through the merger of Mylan and Upjohn, two of the world’s leading generic and specialty pharmaceutical companies. The company is headquartered in Canonsburg, Pennsylvania and has operations in more than 165 countries. Viatris is a global leader in the development, manufacture, and distribution of generic and specialty pharmaceuticals, biologics, and consumer health products. The company’s mission is to provide access to high-quality medicines and healthcare solutions to people around the world.
===History of Viatris===

Viatris was formed in 2020 through the merger of Mylan and Upjohn, two of the world’s leading generic and specialty pharmaceutical companies. Mylan was founded in 1961 and Upjohn was founded in 1886. The merger of the two companies created a global healthcare leader with a broad portfolio of products and services. The company has a presence in more than 165 countries and employs more than 35,000 people.
===Business Model of Viatris===

Viatris’ business model is focused on providing access to high-quality medicines and healthcare solutions to people around the world. The company’s portfolio includes generic and specialty pharmaceuticals, biologics, and consumer health products. Viatris is focused on providing innovative solutions to address unmet medical needs and to improve patient outcomes. The company is also committed to providing access to affordable medicines and healthcare solutions to people in need.
===Financial Performance of Viatris===

Viatris has reported strong [[Financial Performance|financial performance]] since its formation in 2020. The company reported total revenues of $14.3 billion in 2020, an increase of 8.3% compared to the prior year. The company’s [[Net Income|net income]] was $1.2 billion in 2020, an increase of 11.3% compared to the prior year. Viatris’ strong financial performance is driven by its focus on providing access to high-quality medicines and healthcare solutions to people around the world.
===Conclusion===

Viatris is a global healthcare company that was formed in 2020 through the merger of Mylan and Upjohn. The company is focused on providing access to high-quality medicines and healthcare solutions to people around the world. Viatris has reported strong financial performance since its formation, with total revenues of $14.3 billion in 2020 and net income of $1.2 billion. The company’s strong financial performance is driven by its focus on providing access to high-quality medicines and healthcare solutions to people around the world